Samuels, Mark
Karakostas, Christos
Besta, Simoni
Lauer Betrán, Andrea
Tsilingiri, Katerina
Turner, Charlotte
Shirazi Nia, Reza
Poudine, Niloufar
Goodyear, Richard
Jones, William
Klinakis, Apostolos
Giamas, Georgios
Funding for this research was provided by:
Action Against Cancer (G1828)
Article History
Received: 9 January 2025
Accepted: 28 April 2025
First Online: 23 May 2025
Declarations
:
: The research in this study using PBMCs was approved by the research ethics committee of Sciences and Technology (C-REC) at the University of Sussex (Reference Number: ER/MS2207/1) on the 14 th of June 2023. Written informed consent was obtained from all study participants.The animal studies were conducted in in the Animal House Facility of the Biomedical Research Foundation of the Academy of Athens (BRFAA, Greece). All procedures for the care and treatment of the animals were approved by the Institutional Committee on Ethics of Animal Experiments, and studies were conducted in full compliance with FELASA (Federation of Laboratory Animal Science Associations) recommendations. Ethics number: 1385947/27–12-2022.The 4T1 mouse model was conducted in the animal experiment centre of Zhejiang Chinese Medicine University. Mouse experiments were approved by the Experimental Animal Ethics Committee of Zhejiang Chinese Medicine University (approval number: IACUC-20250120–18).
: Not applicable.
: The authors declare no competing interests.